
Doctor Annika Weidenhammer
AKH Wien, Vienna (Austria)
Follow
Contributor content
Presentation
Factors limiting up-titration only concern a fraction of advanced HFrEF patients and might improve over time
Presentation
HFrEF phenotyping in real life
Presentation
CILP-1 as a new biomarker for RVD
Presentation
Temporal evolution of the key neurohumoral regulator renin in chronic stable HFrEF
Presentation

